Cargando…

In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells

Chronic myelogenous leukemia (CML) is a malignant hematological disorder mainly caused by the Bcr-Abl tyrosine kinase. While Bcr-Abl inhibitors including Imatinib showed antitumor efficacy on many CML patients, resistance was frequently reported in recent years. Therefore, novel drugs for CML are st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qianxiang, Chen, Yali, Chen, Xi, Zhao, Wennan, Zhong, Yuxu, Wang, Ran, Jin, Meihua, Qiu, Yuling, Kong, Dexin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870707/ https://www.ncbi.nlm.nih.gov/pubmed/27194941 http://dx.doi.org/10.7150/ijbs.14878

Ejemplares similares

Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells
por: Zhou, Qianxiang, et al.
Publicado: (2017)

Atorvastatin Exerts Antileukemia Activity via Inhibiting Mevalonate-YAP Axis in K562 and HL60 Cells
por: Zhang, Lei, et al.
Publicado: (2019)

In Vitro Antimetastatic Effect of Phosphatidylinositol 3-Kinase Inhibitor ZSTK474 on Prostate Cancer PC3 Cells
por: Zhao, Wennan, et al.
Publicado: (2013)

ZSTK474 Sensitizes Glioblastoma to Temozolomide by Blocking Homologous Recombination Repair
por: Jiao, Wenhui, et al.
Publicado: (2022)

Antiproliferative Effect of Aaptamine on Human Chronic Myeloid Leukemia K562 Cells
por: Jin, Meihua, et al.
Publicado: (2011)

ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells
por: Wang, Yaochen, et al.
Publicado: (2016)

The Mechanism of Bufalin-Induced Apoptosis of K562/A02
por: Xie, Ying, et al.
Publicado: (2019)

Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
por: Namatame, Nachi, et al.
Publicado: (2018)

Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5
por: Chen, Yali, et al.
Publicado: (2017)

Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury
por: Wang, Po, et al.
Publicado: (2016)

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Effect of magnetic nanoparticles of Fe(3)O(4) and wogonin on the reversal of multidrug resistance in K562/A02 cell line
por: Cheng, Jian, et al.
Publicado: (2012)

Effect of magnetic nanoparticles of Fe(3)O(4) and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
por: Cheng, Jian, et al.
Publicado: (2009)

Reversal in multidrug resistance by magnetic nanoparticle of Fe(3)O(4) loaded with adriamycin and tetrandrine in K562/A02 leukemic cells
por: Chen, Baoan, et al.
Publicado: (2008)

Proteomic Analysis of Quercetin-Treated K562 Cells
por: Brisdelli, Fabrizia, et al.
Publicado: (2019)

Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
por: WANG, LEI, et al.
Publicado: (2014)

Establishment and molecular characterization of decitabine‐resistant K562 cells
por: Wen, Xiang‐Mei, et al.
Publicado: (2019)

Effects of Clostridium difficile toxin A on K562/A02 cell proliferation, apoptosis and multi-drug resistance
por: Xi, Yaming, et al.
Publicado: (2018)

Characterization of an Etoposide‐resistant Human K562 Cell Line, K/eto
por: Sugawara, Isamu, et al.
Publicado: (1991)

Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells
por: Zhang, Jian-Ye, et al.
Publicado: (2013)

Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line
por: Li, Nainong, et al.
Publicado: (2015)

Synergistic effect of the combination of nanoparticulate Fe(3)O(4) and Au with daunomycin on K562/A02 cells
por: Chen, Bao-An, et al.
Publicado: (2008)

Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
por: Han, Weidong, et al.
Publicado: (2011)

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells
por: Bertazza, Loris, et al.
Publicado: (2015)

Effects of THAP11 on Erythroid Differentiation and Megakaryocytic Differentiation of K562 Cells
por: Kong, Xiang-Zhen, et al.
Publicado: (2014)

Apoptotic Mechanism of Human Leukemia K562/A02 Cells Induced by Magnetic Ferroferric Oxide Nanoparticles Loaded with Wogonin
por: Peng, Miao-Xin, et al.
Publicado: (2016)

Proton NMR visible mobile lipid signals in sensitive and multidrug-resistant K562 cells are modulated by rafts
por: Mannechez, Aurélie, et al.
Publicado: (2005)

Effects of Decitabine on the proliferation of K562 cells and the expression of DR4 gene
por: Zhang, Wenhui, et al.
Publicado: (2018)

Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells
por: KANG, QINGWEI, et al.
Publicado: (2015)

Co-migration and internalization of transferrin and its receptor on K562 cells
Publicado: (1983)

Induction of Erythroid Differentiation by 5‐Fluorouracil in K562 Leukemia Cells
por: Yang, Ya‐Wun, et al.
Publicado: (1995)

Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
por: Zu, Yaqiong, et al.
Publicado: (2014)

COL-3-Induced Molecular and Ultrastructural Alterations in K562 Cells
por: Fares, Mona, et al.
Publicado: (2022)

Protective effect of Bosutinib with caspase inhibitors on human K562 cells
por: Baty, Roua S.
Publicado: (2022)

Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
por: Wang, Jun, et al.
Publicado: (2011)

Voltage-Gated K(+) Channel, K(v)3.3 Is Involved in Hemin-Induced K562 Differentiation
por: Song, Min Seok, et al.
Publicado: (2016)

Heme-Oxygenases during Erythropoiesis in K562 and Human Bone Marrow Cells
por: Alves, Liliane R., et al.
Publicado: (2011)

Regulation of hTERT by BCR-ABL at multiple levels in K562 cells
por: Chai, Juin Hsien, et al.
Publicado: (2011)

Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells
por: Tan, Fang, et al.
Publicado: (2010)

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_65q2520s6a9aeltou5b5ornd90